A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan Rogel Cancer Center
- Study ID
- NCT07542405
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- BRCA1-Related Hereditary Breast and Ovarian Cancer Syndrome
- BRCA2-Related Hereditary Breast and Ovarian Cancer Syndrome
- Hereditary Neoplastic Syndrome
- Lynch Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Discussion — OTHERAncillary studies
- Internet-Based Intervention — OTHERReceive access to the Kindred web-based portal
- Internet-Based Intervention — OTHERShare information and invite relatives
- Survey Administration — OTHERAncillary studies
- Telephone-Based Intervention — BEHAVIORALReceive check-in calls
Study Details
This clinical trial studies whether a web-based program, Kindred, works to improve the understanding of genetic cancer risk and cancer genetic testing in African American families. Between 5% and 10% of all cancers are caused by genetic changes that are hereditary, which means that they run in families. Some kinds of cancer or a family history of cancer means individuals are more likely to have a genetic change. If a genetic change is identified in a family, other relatives can choose to undergo hereditary cancer genetic testing to better understand their cancer risk. In families where a genetic change is not identified, or results are uncertain, relatives may also benefit from discussing their cancer risk with providers and, in some cases, getting hereditary cancer genetic testing themselves. Research has shown that African Americans are less likely than other racial groups to engage in cancer genetic testing. Kindred is an online tool that provides information so individuals can learn about their cancer genetic test results, how cancer genetic testing can help individuals and families understand their overall cancer risk (and strategies for reducing risk), and ways to talk with each other about cancer risk and health. This may be an effective way to improve the understanding of genetic cancer risk and cancer genetic testing in African American families.
Key Dates
- Start date
- Jun 15, 2026
- Status verified
- May 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Probands (Kindred, invite relatives)Probands receive access to the Kindred web-based portal on study consisting of the following sections: Share and Invite, Meaning of Results, Implications of Results, Communication with Family, Dissemination Plan, Looking Ahead, Glossary, FAQ, Resources List, and Public-Facing Website Information. Probands may optionally share information about their test results and invite \>= 4 relatives to join the study via the Share and Invite section in the Kindred portal. Probands also receive two check-in calls at 2- and 4- weeks post-baseline.
- Experimental: Relatives (Kindred)Invited relatives receive access to the Kindred web-based portal on study consisting of the following sections: Meaning of Results, Implications of Results, Communication with Family, Getting Testing, Looking Ahead, Glossary, FAQ, Resources List, and Public-Facing Website Information.
Primary Outcome Measure
Recruitment rates (Feasibility) [ Time Frame: Up to 2 years ]
Central Contacts
- Cacner AnswerLine1-800-865-1125
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan Rogel Cancer Center | Ann Arbor | Michigan | 48109 | Katrina Ellis Katrina Ellis, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
Related Studies
- The Cancer of the Pancreas Screening-5 CAPS5)StudyPHASE3 · Recruiting · Johns Hopkins University · New Haven, Connecticut
- Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer SyndromesRecruiting · University of Michigan Rogel Cancer Center · Ann Arbor, Michigan
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Pre-myeloid Cancer and Bone Marrow Failure Clinic StudyRecruiting · Mayo Clinic · Scottsdale, Arizona